Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q8WY91
UPID:
THAP4_HUMAN
Alternative names:
Ferric Homo sapiens nitrobindin; THAP domain-containing protein 4
Alternative UPACC:
Q8WY91; Q53NU7; Q6GRN0; Q6IPJ3; Q9NW26; Q9Y325
Background:
Peroxynitrite isomerase THAP4, also known as Ferric Homo sapiens nitrobindin and THAP domain-containing protein 4, plays a crucial role in cellular defense mechanisms. It binds heme, scavenges peroxynitrite, and protects L-tyrosine from nitration, acting as a peroxynitrite isomerase. This protein's ability to detoxify reactive nitrogen and oxygen species (RNS and ROS) and bind nitric oxide (NO) underscores its importance in cellular homeostasis.
Therapeutic significance:
Understanding the role of Peroxynitrite isomerase THAP4 could open doors to potential therapeutic strategies.